Trial intelligence / Profile preview

MDMA receptor mechanism study on memory impairment and impulsivity

NL-OMON23877Unknown

Sponsor
NWO
Start
Mar 2010
Modality
Small Molecules
Countries
1
01

Overview

Double-blind trial of midomafetamine, ketanserin and pindolol (6 arms), sponsored by NWO. Primary endpoints: Neurocognitive measures of memory and Neurocognitive measures of impulse control. Status: unknown.

02

Drugs

midomafetamineketanserinpindolol

Beyond the preview

Go deeper on NL-OMON23877.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON23877.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call